5-[(3S)-3-aminopiperidin-1-yl]-N-[3-(difluoromethyl)-1-[1-[[3-[3-(2,4-dioxopiperidin-1-yl)-4-methylbenzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
C45H57F2N11O4 — CID 172879076
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(3S)-3-aminopiperidin-1-yl]-N-[3-(difluoromethyl)-1-[1-[[3-[3-(2,4-dioxopiperidin-1-yl)-4-methylbenzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
5-[(3S)-3-aminopiperidin-1-yl]-N-[3-(difluoromethyl)-1-[1-[[3-[3-(2,4-dioxopiperidin-1-yl)-4-methylbenzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 172879076) has the molecular formula C45H57F2N11O4 and a molecular weight of 854.02 g/mol. Its IUPAC name is 5-[(3S)-3-aminopiperidin-1-yl]-N-[3-(difluoromethyl)-1-[1-[[3-[3-(2,4-dioxopiperidin-1-yl)-4-methylbenzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
Molecular Properties
| Compound Name | 5-[(3S)-3-aminopiperidin-1-yl]-N-[3-(difluoromethyl)-1-[1-[[3-[3-(2,4-dioxopiperidin-1-yl)-4-methylbenzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
|---|---|
| PubChem CID | 172879076 |
| Molecular Formula | C45H57F2N11O4 |
| Molecular Weight | 854.02 g/mol |
| Exact Mass | 853.46 |
| IUPAC Name | 5-[(3S)-3-aminopiperidin-1-yl]-N-[3-(difluoromethyl)-1-[1-[[3-[3-(2,4-dioxopiperidin-1-yl)-4-methylbenzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
| SMILES | Cc1ccc(C(=O)N2CCC3(CCC(CN4CCC(n5cc(NC(=O)c6cnn7ccc(N8CCC[C@H](N)C8)nc67)c(C(F)F)n5)CC4)CC3)CC2)cc1N1CCC(=O)CC1=O |
| InChI | InChI=1S/C45H57F2N11O4/c1-29-4-5-31(23-37(29)56-19-10-34(59)24-39(56)60)44(62)54-21-14-45(15-22-54)12-6-30(7-13-45)26-53-17-8-33(9-18-53)58-28-36(40(52-58)41(46)47)50-43(61)35-25-49-57-20-11-38(51-42(35)57)55-16-2-3-32(48)27-55/h4-5,11,20,23,25,28,30,32-33,41H,2-3,6-10,12-19,21-22,24,26-27,48H2,1H3,(H,50,61)/t32-/m0/s1 |
| InChIKey | VRFVHGBQFADDSX-YTTGMZPUSA-N |
| XLogP | 5.80 |
| TPSA | 167.30 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 62 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 854.02 |
| LogP ≤ 5 | 5.80 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172879076 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.